Kawasaki disease: Heart disease during childhood;Enfermedad de Kawasaki: Afección cardiaca durante la infancia

Revista Espanola de Cardiologia

Volumn 59, Issue 4, 2006, Pages 387-390

  Schroh, Ana M ^a,b   Domínguez, Pablo ^a   Laghezza, Lidia B ^a   Melonari, Pablo A ^a   Olguín, Marisa ^a   Miatello, Roberto ^a  

^a Hospital Pediátrico Dr H J Notti of Mendoza   (Argentina)

^b NONE   (Argentina)

Author keywords

Coronary aneurysm; Kawasaki disease

Indexed keywords

ACETYLSALICYLIC ACID; IMMUNOGLOBULIN;

AGE; ARTERY DIAMETER; ARTICLE; CARDITIS; CHILD; CHILDHOOD DISEASE; CORONARY ARTERY ANEURYSM; CORONARY ARTERY ANOMALY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY OBSTRUCTION; CORONARY RISK; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEVER; HEART DISEASE; HUMAN; INFANT; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MORTALITY; MUCOCUTANEOUS LYMPH NODE SYNDROME; OUTCOMES RESEARCH; PREDICTION; RISK FACTOR;

EID: 33744798472     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0300-8932(06)74647-4     Document Type: Article

References (13)

1. Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile febrile mucocutaneous lymph node syndrome prevailing in Japan. Pediatrics. 1974;54:271-6.
2. Lekuona I, Laraudogoitia E, Palomar S, Salcedo A, Zumalde J, Morillas M. ¿Ectasia coronaria aterosclerótica o síndrome linfomucocutáneo del adulto (enfermedad de Kawasaki)? Rev Esp Cardiol. 1999;52:63-6.
3. Dajani AS, Taubert KA, Takahashi M, Bierman FZ, Freed MD, Ferrieri P, et al. Guidelines for long-term management of patients with Kawasaki disease. Report from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 1994;89:916-2.
4. Witt MT, Minich LL, Bohnsack JF, Young PC. Kawasaki disease: more patients are being diagnosed who do not meet American Heart Association criteria. Pediatrics. 1999;104:e10.
5. D Zorzi A, Colan SD, Gauvreau K, Baker AL, Sundel RP, Newburger JW. Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J Pediatr. 1998;133:254-.
6. Research Committee on Kawasaki Disease. Report of Subcommittee on Standardization of Diagnostic Criteria and Reporting of Coronary Artery Lesions in Kawasaki Disease. Tokyo: Ministry of Health and Welfare; 1984.
7. Kato H, Sugimura T, Akagy T, Sato N, Hashino K, Maeno Y, et al. Long-term consequences of Kawasaki disease. A 10 to 21 year follow-up study of 594 patients. Circulation. 1996;94:1379-85.
8. Kondo C, Nakanishi T, Sonobe T, Katsunori T, Momma K, Kusakabe T. Scintigraphic monitoring of coronary artery occlusion due to Kawasaki disease. Am J Cardiol. 1993;71:681-5.
9. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association. Pediatrics. 2004;114:1708-33.
10. Stockheim JA, Innocentini N, Shulman ST. Kawasaki disease in older children and adolescents. J Pediatr. 2000;137:250-2.
11. Gidding S, Duffy C, Pajcic S, Berdusis K, Shulman S. Usefulness of echocardiographic evidence of pericardial effusion and mitral regurgitation during the acute stage in predicting development of coronary arterial aneurysms in the late stage of Kawasaki disease. Am J Cardiol. 1987;60:76-9.
12. Nakano H, Ueda K, Saito A, Tsuchitani Y, Kawamori J, Miyake T, et al. Scoring method for identifying patients with Kawasaki disease at high risk of coronary artery aneurysms. Am J Cardiol. 1986;58:739-42.
13. Kitamura S. Surgical management for cardiovascular lesions in Kawasaki disease. Cardiol Young. 1991;1:249-53.